相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Baseline Plasma Cell Gene Signature Predicts Improvement in Systemic Sclerosis Skin Scores Following Treatment With Inebilizumab (MEDI-551) and Correlates With Disease Activity in Systemic Lupus Erythematosus and Chronic Obstructive Pulmonary Disease
Katie Streicher et al.
ARTHRITIS & RHEUMATOLOGY (2018)
Anifrolumab, an Anti-Interferon-α Receptor Monoclonal Antibody, in Moderate-to-Severe Systemic Lupus Erythematosus
Richard Furie et al.
ARTHRITIS & RHEUMATOLOGY (2017)
Type I interferons suppress viral replication but contribute to T cell depletion and dysfunction during chronic HIV-1 infection
Liang Cheng et al.
JCI INSIGHT (2017)
Sifalimumab, an anti-interferon-α monoclonal antibody, in moderate to severe systemic lupus erythematosus: a randomised, double-blind, placebo-controlled study
Munther Khamashta et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Altered type II interferon precedes autoantibody accrual and elevated type I interferon activity prior to systemic lupus erythematosus classification
Melissa E. Munroe et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Targeted therapeutics in SLE: emerging strategies to modulate the interferon pathway
Shereen Oon et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2016)
A Transcriptional Signature of Fatigue Derived from Patients with Primary Sjogren's Syndrome
Katherine James et al.
PLOS ONE (2015)
A phase 1b clinical trial evaluating sifalimumab, an anti-IFN-alpha monoclonal antibody, shows target neutralisation of a type I IFN signature in blood of dermatomyositis and polymyositis patients
Brandon W. Higgs et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Advances in understanding the role of type I interferons in systemic lupus erythematosus
Mary K. Crow
CURRENT OPINION IN RHEUMATOLOGY (2014)
Type I Interferon in the Pathogenesis of Lupus
Mary K. Crow
JOURNAL OF IMMUNOLOGY (2014)
The Plasma Cell Signature in Autoimmune Disease
Katie Streicher et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Type I interferons in Sjogren's syndrome
Yihong Yao et al.
AUTOIMMUNITY REVIEWS (2013)
GSVA: gene set variation analysis for microarray and RNA-Seq data
Sonja Haenzelmann et al.
BMC BIOINFORMATICS (2013)
The interferon signature in autoimmune diseases
Lars Ronnblom et al.
CURRENT OPINION IN RHEUMATOLOGY (2013)
Molecular Profiling to Diagnose a Case of Atypical Dermatomyositis
Kavita Y. Sarin et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
SLE Peripheral Blood B Cell, T Cell and Myeloid Cell Transcriptomes Display Unique Profiles and Each Subset Contributes to the Interferon Signature
Amy M. Becker et al.
PLOS ONE (2013)
Genomic signatures characterize leukocyte infiltration in myositis muscles
Wei Zhu et al.
BMC MEDICAL GENOMICS (2012)
Relationship between disease activity and type 1 interferon-and other cytokine-inducible gene expression in blood in dermatomyositis and polymyositis
S. A. Greenberg et al.
GENES AND IMMUNITY (2012)
Identification of activated cytokine pathways in the blood of systemic lupus erythematosus, myositis, rheumatoid arthritis, and scleroderma patients
Brandon W. Higgs et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2012)
Interferon and Biologic Signatures in Dermatomyositis Skin: Specificity and Heterogeneity across Diseases
David Wong et al.
PLOS ONE (2012)
Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway
Brandon W. Higgs et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Type I Interferon and Systemic Lupus Erythematosus
Keith B. Elkon et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2011)
Autoantibodies in systemic lupus erythematosus: comparison of historical and current assessment of seropositivity
A. Ippolito et al.
LUPUS (2011)
The type I interferon system in the development of lupus
Lars Ronnblom et al.
SEMINARS IN IMMUNOLOGY (2011)
Dissecting Interferon-Induced Transcriptional Programs in Human Peripheral Blood Cells
Simon J. Waddell et al.
PLOS ONE (2010)
Use of type I interferon-inducible mRNAs as pharmacodynamic markers and potential diagnostic markers in trials with sifalimumab, an anti-IFN alpha antibody, in systemic lupus erythematosus
Yihong Yao et al.
ARTHRITIS RESEARCH & THERAPY (2010)
Neutralization of Interferon-alpha/beta-Inducible Genes and Downstream Effect in a Phase I Trial of an Anti-Interferon-alpha Monoclonal Antibody in Systemic Lupus Erythematosus
Yihong Yao et al.
ARTHRITIS AND RHEUMATISM (2009)
Signalling pathways leading to IFN-alpha production in human plasmacytoid dendritic cell and the possible use of agonists or antagonists of TLR7 and TLR9 in clinical indications
C. Guiducci et al.
JOURNAL OF INTERNAL MEDICINE (2009)
Type I Interferon: Potential Therapeutic Target for Psoriasis?
Yihong Yao et al.
PLOS ONE (2008)
Interferon and granulopoiesis signatures in systemic lupus erythematosus blood
L Bennett et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus
EC Baechler et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
分享论文
